Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to 24.43%.

  • Healthequity's EBIT Margin rose 178900.0% to 24.43% in Q4 2025 from the same period last year, while for Oct 2025 it was 22.74%, marking a year-over-year increase of 89100.0%. This contributed to the annual value of 13.53% for FY2025, which is 17600.0% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's EBIT Margin is 24.43%, which was up 178900.0% from 27.5% recorded in Q3 2025.
  • Healthequity's 5-year EBIT Margin high stood at 27.5% for Q3 2025, and its period low was 13.4% during Q1 2022.
  • For the 5-year period, Healthequity's EBIT Margin averaged around 8.45%, with its median value being 8.01% (2024).
  • Per our database at Business Quant, Healthequity's EBIT Margin plummeted by -125600bps in 2022 and then soared by 190600bps in 2023.
  • Quarter analysis of 5 years shows Healthequity's EBIT Margin stood at 0.2% in 2021, then soared by 1361bps to 2.56% in 2022, then surged by 383bps to 12.4% in 2023, then crashed by -47bps to 6.53% in 2024, then soared by 274bps to 24.43% in 2025.
  • Its last three reported values are 24.43% in Q4 2025, 27.5% for Q3 2025, and 25.11% during Q2 2025.